Keyphrases
Aggressive Tumor
20%
Agonist Binding
20%
Amino Acids
20%
CCK2
60%
Cholecystokinin
100%
Cholecystokinin-2 Receptor
100%
Co-expression
20%
Colonic Cancer
20%
Colorectal Cancer
20%
Fold Increase
20%
G Protein-coupled Receptor
20%
Gastrin-releasing Peptide Receptor (GRPr)
80%
HEK293 Cells
20%
Human Colon Cancer
20%
Human Colorectal Cancer
20%
Human Pancreatic Cancer
40%
In Vitro Kinase Assay
20%
Increased Activity
20%
Kinase Activity
20%
Neoplastic Cells
20%
Nonmalignant
20%
Pancreatic Cancer
40%
Receptor Splice Variants
100%
Receptor-interacting Protein Kinase 1 (RIPK1)
20%
Splice Variant
40%
Src Kinase
60%
Src Tyrosine Kinase
100%
Third Intracellular Loop
20%
Neuroscience
Agonist
100%
Amino Acid
20%
Cell Line
20%
Cholecystokinin
100%
Cholecystokinin B Receptor
100%
G Protein Coupled Receptor
20%
In Vitro
20%
Kinase
80%
Receptor Protein
20%
Receptor Tyrosine Kinase
100%
Tyrosine Kinase
100%
Pharmacology, Toxicology and Pharmaceutical Science
Amino Acid
20%
Cholecystokinin
100%
Cholecystokinin B Receptor
100%
Colon Carcinoma
40%
Colorectal Carcinoma
40%
G Protein Coupled Receptor
20%
Malignant Neoplasm
60%
Pancreas Cancer
80%
Phosphotransferase
80%
Protein Tyrosine Kinase
100%
Receptor Protein
20%
Biochemistry, Genetics and Molecular Biology
Agonist
100%
Amino Acids
16%
Cholecystokinin
100%
Colon
16%
G Protein Coupled Receptor
16%
Gastrin
66%
Kinase
66%
Phosphotransferase
66%
Receptor Tyrosine Kinase
100%
Tyrosine Kinase
100%